规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
---|---|---|---|---|---|---|---|---|---|
0mg | ¥ ƅŔźǯǯ | > | -- | -- | -- | 2 | -- | ¥ ƅŔźǯǯ | - + |
20mg | ¥ ȀňŔźǯǯ | > | -- | 1 | ¥ ȀňŔźǯǯ | - + | |||
1g | ¥ șșňźǯǯ | > | -- | -- | -- | -- | 1 | ¥ șșňźǯǯ | - + |
g | ¥ ȀƏŔƏźǯǯ | 6 | -- | 1 | -- | 1 | 1 | ¥ ȀƏŔƏźǯǯ | - + |
g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
2g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
0g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
186.07
[1]. Kikuchi E, et al. Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts. Cancer Gene Th
[2]. Sorscher EJ, et al. In vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase. Cancer Chemother Pharmacol. 2012 Aug;70(2):321-9.
[3]. D D Von Hoff, et al. Phase I clinical trials with fludarabine phosphate. Semin Oncol. 1990 Oct;17( Suppl 8):33-8.
[]. H G Chun, et al. Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies. J Clin Oncol. 1991 Jan;9(1):17-88.
[]. H M Kantarjian, et al. Fludarabine phosphate therapy in other lymphoid malignancies. Semin Oncol. 1990 Oct;17( Suppl 8):66-70.
H31-H361
P280-P0-P01